CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-16 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +856 | 9,623.99 | ||
| 2024-02-16 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −414 | $219.08 | $91K | 9,209.99 |
| 2024-02-16 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +404 | 9,613.99 | ||
| 2024-02-16 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −196 | $219.08 | $43K | 9,417.99 |
| 2024-02-16 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Performance Stock Unit | −856 | 0 | ||
| 2024-02-16 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −404 | 504 | ||
| 2024-02-16 | Murphy Nicole Head of Pharm Ops and Tech | Other disposition · Restricted Stock Unit | −504 | 0 | ||
| 2024-02-16 | Singhal Priya Head of Development | Option exercise 10b5-1 | +819 | 5,335.09 | ||
| 2024-02-16 | Singhal Priya Head of Development | Shares withheld for taxes 10b5-1 | −295 | $219.08 | $65K | 5,040.09 |
| 2024-02-16 | Singhal Priya Head of Development | Option exercise 10b5-1 | +389 | 5,429.09 | ||
| 2024-02-16 | Singhal Priya Head of Development | Shares withheld for taxes 10b5-1 | −173 | $219.08 | $38K | 5,256.09 |
| 2024-02-16 | Singhal Priya Head of Development | Sale 10b5-1 | −108 | $221.49 | $24K | 5,148.09 |
| 2024-02-16 | Singhal Priya Head of Development | Option exercise · Performance Stock Unit 10b5-1 | −819 | 0 | ||
| 2024-02-16 | Singhal Priya Head of Development | Option exercise · Restricted Stock Unit 10b5-1 | −389 | 485 | ||
| 2024-02-16 | Singhal Priya Head of Development | Other disposition · Restricted Stock Unit 10b5-1 | −485 | 0 | ||
| 2024-02-15 | Rowinsky Eric K Director | Purchase | +455 | $222.54 | $101K | 20,629 |
| 2024-02-12 | Singhal Priya Head of Development | Sale 10b5-1 | −419 | $239.45 | $100K | 4,516.09 |
| 2024-02-09 | Gregory Ginger EVP, Human Resources | Option exercise | +2,158 | 11,777.72 | ||
| 2024-02-09 | Gregory Ginger EVP, Human Resources | Shares withheld for taxes | −634 | $240.98 | $153K | 11,143.72 |
| 2024-02-09 | Gregory Ginger EVP, Human Resources | Option exercise · Restricted Stock Unit | −2,158 | 2,159 |
Page 16 of 29 · 579 trades